{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:17:15Z","timestamp":1791389835684,"version":"4.3.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RC IZSVe 08\/2009"],"award-info":[{"award-number":["RC IZSVe 08\/2009"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013850","name":"Helmut Horten Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013850","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013905","name":"Swiss Vaccine Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013905","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FAO\/National RC for Rabies, IZSVe\u2010Italy"},{"name":"IAEA Laboratories\u2010Austria"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2016,4,1]]},"DOI":"10.15252\/emmm.201505986","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T22:00:27Z","timestamp":1458338427000},"page":"407-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Development of broad\u2010spectrum human monoclonal antibodies for rabies post\u2010exposure prophylaxis"],"prefix":"10.1038","volume":"8","author":[{"given":"Paola","family":"De Benedictis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Minola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rota Nodari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Zecchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Salomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Foglierini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Agatic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizia","family":"Vanzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lavenir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lepelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cattoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Capua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sallusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lanzavecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Bourhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4046-7222","authenticated-orcid":false,"given":"Davide","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"issue":"Pt 9","key":"BFEMMM201505986_CR1","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1099\/0022-1317-78-9-2319","volume":"78","author":"B Amengual","year":"1997","unstructured":"Amengual B, Whitby JE, King A, Cobo JS, Bourhy H (1997) Evolution of European bat lyssaviruses. J Gen Virol 78(Pt 9): 2319\u20132328","journal-title":"J Gen Virol"},{"key":"BFEMMM201505986_CR2","first-page":"407","volume":"39","author":"BG Archer","year":"1968","unstructured":"Archer BG, Dierks RE (1968) Effects of homologous or heterologous antiserum on neutralizing\u2010antibody response to rabies vaccine. Bull World Health Organ 39: 407\u2013417","journal-title":"Bull World Health Organ"},{"key":"BFEMMM201505986_CR3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3201\/eid1905.121071","volume":"19","author":"N Arechiga Ceballos","year":"2013","unstructured":"Arechiga Ceballos N, Vazquez Moron S, Berciano JM, Nicolas O, Aznar Lopez C, Juste J, Rodriguez Nevado C, Aguilar Setien A, Echevarria JE (2013) Novel lyssavirus in bat, Spain. Emerg Infect Dis 19: 793\u2013795","journal-title":"Emerg Infect Dis"},{"key":"BFEMMM201505986_CR4","first-page":"593","volume":"14","author":"P Atanasiu","year":"1956","unstructured":"Atanasiu P, Bahmanyar M, Baltazard M, Fox JP, Habel K, Kaplan MM, Kissling RE, Komarov A, Koprowski H, Lepine P et\u00a0al (1956) Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non\u2010exposed persons. Bull World Health Organ 14: 593\u2013611","journal-title":"Bull World Health Organ"},{"key":"BFEMMM201505986_CR5","first-page":"103","volume":"25","author":"P Atanasiu","year":"1961","unstructured":"Atanasiu P, Cannon DA, Dean DJ, Fox JP, Habel K, Kaplan MM, Kissling RE, Koprowski H, Lepine P, Perez Gallardo F (1961) Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non\u2010exposed persons. 3. Bull World Health Organ 25: 103\u2013114","journal-title":"Bull World Health Organ"},{"key":"BFEMMM201505986_CR6","first-page":"361","volume":"36","author":"P Atanasiu","year":"1967","unstructured":"Atanasiu P, Dean DJ, Habel K, Kaplan MM, Koprowski H, Lepine P, Serie C (1967) Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non\u2010exposed persons. 4. Bull World Health Organ 36: 361\u2013365","journal-title":"Bull World Health Organ"},{"key":"BFEMMM201505986_CR7","first-page":"384","volume":"3","author":"V Babes","year":"1889","unstructured":"Babes V, Lepp M (1889) Recherches sur la vaccination antirabique. Ann Inst Pasteur 3: 384\u2013390","journal-title":"Ann Inst Pasteur"},{"key":"BFEMMM201505986_CR8","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","volume":"75","author":"H Badrane","year":"2001","unstructured":"Badrane H, Bahloul C, Perrin P, Tordo N (2001) Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J Virol 75: 3268\u20133276","journal-title":"J Virol"},{"key":"BFEMMM201505986_CR9","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","volume":"79","author":"AB Bakker","year":"2005","unstructured":"Bakker AB, Marissen WE, Kramer RA, Rice AB, Weldon WC, Niezgoda M, Hanlon CA, Thijsse S, Backus HH, de Kruif J et\u00a0al (2005) Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in\u00a0vitro escape mutants. J Virol 79: 9062\u20139068","journal-title":"J Virol"},{"key":"BFEMMM201505986_CR10","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","volume":"26","author":"AB Bakker","year":"2008","unstructured":"Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, Brink MF, Lagerwerf F, Worst S, van Corven E, Kostense S et\u00a0al (2008) First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine 26: 5922\u20135927","journal-title":"Vaccine"},{"key":"BFEMMM201505986_CR11","first-page":"747","volume":"13","author":"M Baltazard","year":"1955","unstructured":"Baltazard M, Bahmanyar M (1955) Field trials with rabies vaccine on persons bitten by rabid wolves. Bull World Health Organ 13: 747\u2013772","journal-title":"Bull World Health Organ"},{"key":"BFEMMM201505986_CR12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","volume":"12","author":"L Both","year":"2012","unstructured":"Both L, Banyard AC, van Dolleweerd C, Horton DL, Ma JK, Fooks AR (2012) Passive immunity in the prevention of rabies. Lancet Infect Dis 12: 397\u2013407","journal-title":"Lancet Infect Dis"},{"key":"BFEMMM201505986_CR13","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/jcm.30.9.2419-2426.1992","volume":"30","author":"H Bourhy","year":"1992","unstructured":"Bourhy H, Kissi B, Lafon M, Sacramento D, Tordo N (1992) Antigenic and molecular characterization of bat rabies virus in Europe. J Clin Microbiol 30: 2419\u20132426","journal-title":"J Clin Microbiol"},{"key":"BFEMMM201505986_CR14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/viro.1993.1236","volume":"194","author":"H Bourhy","year":"1993","unstructured":"Bourhy H, Kissi B, Tordo N (1993) Molecular diversity of the Lyssavirus genus. Virology 194: 70\u201381","journal-title":"Virology"},{"key":"BFEMMM201505986_CR15","doi-asserted-by":"crossref","first-page":"19166","DOI":"10.2807\/ese.14.13.19166-en","volume":"14","author":"H Bourhy","year":"2009","unstructured":"Bourhy H, Goudal M, Mailles A, Sadkowska\u2010Todys M, Dacheux L, Zeller H (2009) Is there a need for anti\u2010rabies vaccine and immunoglobulins rationing in Europe? Euro Surveill 14: 19166","journal-title":"Euro Surveill"},{"key":"BFEMMM201505986_CR16","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","volume":"23","author":"SM Brookes","year":"2005","unstructured":"Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR (2005) Rabies human diploid cell vaccine elicits cross\u2010neutralising and cross\u2010protecting immune responses against European and Australian bat lyssaviruses. Vaccine 23: 4101\u20134109","journal-title":"Vaccine"},{"key":"BFEMMM201505986_CR17","first-page":"303","volume":"45","author":"VJ Cabasso","year":"1971","unstructured":"Cabasso VJ, Loofbourow JC, Roby RE, Anuskiewicz W (1971) Rabies immune globulin of human origin: preparation and dosage determination in non\u2010exposed volunteer subjects. Bull World Health Organ 45: 303\u2013315","journal-title":"Bull World Health Organ"},{"key":"BFEMMM201505986_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-1157(74)80007-7","volume":"2","author":"VJ Cabasso","year":"1974","unstructured":"Cabasso VJ (1974) Properties of rabies immune globulin of human origin. J Biol Stand 2: 43\u201350","journal-title":"J Biol Stand"},{"key":"BFEMMM201505986_CR19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/am.27.3.553-561.1974","volume":"27","author":"VJ Cabasso","year":"1974","unstructured":"Cabasso VJ, Dobkin MB, Roby RE, Hammar AH (1974) Antibody response to a human diploid cell rabies vaccine. Appl Microbiol 27: 553\u2013561","journal-title":"Appl Microbiol"},{"key":"BFEMMM201505986_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","volume":"212","author":"F Cliquet","year":"1998","unstructured":"Cliquet F, Aubert M, Sagne L (1998) Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies\u2010neutralising antibody. J Immunol Methods 212: 79\u201387","journal-title":"J Immunol Methods"},{"key":"BFEMMM201505986_CR21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","volume":"31","author":"D Corti","year":"2013","unstructured":"Corti D, Lanzavecchia A (2013) Broadly neutralizing antiviral antibodies. Annu Rev Immunol 31: 705\u2013742","journal-title":"Annu Rev Immunol"},{"key":"BFEMMM201505986_CR22","first-page":"686","volume-title":"Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses","author":"R Dietzgen","year":"2011","unstructured":"Dietzgen R, Calisher C, Kurath G, Kuzmin I, Rodriguez L, Stone D, Tesh R, Tordo N, Walker P, Wetzel T et\u00a0al (2011) Rhabdoviridae. In Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses, King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (eds), pp 686\u2013714. Oxford, UK: Elsevier"},{"key":"BFEMMM201505986_CR23","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1016\/j.vaccine.2009.06.030","volume":"27","author":"B Dodet","year":"2009","unstructured":"Dodet B, Africa Rabies Bureau (AfroREB) (2009) The fight against rabies in Africa: from recognition to action. Vaccine 27: 5027\u20135032","journal-title":"Vaccine"},{"key":"BFEMMM201505986_CR24","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","volume":"3","author":"HC Ertl","year":"2009","unstructured":"Ertl HC (2009) Novel vaccines to human rabies. PLoS Negl Trop Dis 3: e515","journal-title":"PLoS Negl Trop Dis"},{"key":"BFEMMM201505986_CR25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","volume":"384","author":"AR Fooks","year":"2014","unstructured":"Fooks AR, Banyard AC, Horton DL, Johnson N, McElhinney LM, Jackson AC (2014) Current status of rabies and prospects for elimination. Lancet 384: 1389\u20131399","journal-title":"Lancet"},{"key":"BFEMMM201505986_CR26","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","volume":"193","author":"J Goudsmit","year":"2006","unstructured":"Goudsmit J, Marissen WE, Weldon WC, Niezgoda M, Hanlon CA, Rice AB, Kruif J, Dietzschold B, Bakker AB, Rupprecht CE (2006) Comparison of an anti\u2010rabies human monoclonal antibody combination with human polyclonal anti\u2010rabies immune globulin. J Infect Dis 193: 796\u2013801","journal-title":"J Infect Dis"},{"key":"BFEMMM201505986_CR27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/10635150390235520","volume":"52","author":"S Guindon","year":"2003","unstructured":"Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696\u2013704","journal-title":"Syst Biol"},{"key":"BFEMMM201505986_CR28","first-page":"781","volume":"10","author":"K Habel","year":"1954","unstructured":"Habel K (1954) Antiserum in the prophylaxis of rabies. Bull World Health Organ 10: 781\u2013788","journal-title":"Bull World Health Organ"},{"key":"BFEMMM201505986_CR29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2307\/4589865","volume":"72","author":"K Habel","year":"1957","unstructured":"Habel K (1957) Rabies prophylaxis in man. Public Health Rep 72: 667\u2013673","journal-title":"Public Health Rep"},{"key":"BFEMMM201505986_CR30","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","volume":"9","author":"K Hampson","year":"2015","unstructured":"Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S et\u00a0al (2015) Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis 9: e0003709","journal-title":"PLoS Negl Trop Dis"},{"key":"BFEMMM201505986_CR31","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","volume":"19","author":"CA Hanlon","year":"2001","unstructured":"Hanlon CA, DeMattos CA, DeMattos CC, Niezgoda M, Hooper DC, Koprowski H, Notkins A, Rupprecht CE (2001a) Experimental utility of rabies virus\u2010neutralizing human monoclonal antibodies in post\u2010exposure prophylaxis. Vaccine 19: 3834\u20133842","journal-title":"Vaccine"},{"key":"BFEMMM201505986_CR32","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(00)00516-8","volume":"19","author":"CA Hanlon","year":"2001","unstructured":"Hanlon CA, Niezgoda M, Morrill PA, Rupprecht CE (2001b) The incurable wound revisited: progress in human rabies prevention? Vaccine 19: 2273\u20132279","journal-title":"Vaccine"},{"key":"BFEMMM201505986_CR33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","volume":"111","author":"CA Hanlon","year":"2005","unstructured":"Hanlon CA, Kuzmin IV, Blanton JD, Weldon WC, Manangan JS, Rupprecht CE (2005) Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res 111: 44\u201354","journal-title":"Virus Res"},{"key":"BFEMMM201505986_CR34","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nprot.2007.132","volume":"2","author":"KL Heckman","year":"2007","unstructured":"Heckman KL, Pease LR (2007) Gene splicing and mutagenesis by PCR\u2010driven overlap extension. Nat Protoc 2: 924\u2013932","journal-title":"Nat Protoc"},{"key":"BFEMMM201505986_CR35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-2452(97)83529-5","volume":"95","author":"PT Hooper","year":"1997","unstructured":"Hooper PT, Lunt RA, Gould AR, Samaratunga H, Hyatt AD, Gleeson LJ, Rodwell BJ, Rupprecht CE, Smith JS, Murray PK (1997) A new lyssavirus \u2010 The first endemic rabies\u2010related virus recognized in Australia. Bull Inst Pasteur 95: 209\u2013218","journal-title":"Bull Inst Pasteur"},{"key":"BFEMMM201505986_CR36","doi-asserted-by":"crossref","first-page":"11841","DOI":"10.1128\/JVI.01153-10","volume":"84","author":"DL Horton","year":"2010","unstructured":"Horton DL, McElhinney LM, Marston DA, Wood JL, Russell CA, Lewis N, Kuzmin IV, Fouchier RA, Osterhaus AD, Fooks AR et\u00a0al (2010) Quantifying antigenic relationships among the lyssaviruses. J Virol 84: 11841\u201311848","journal-title":"J Virol"},{"key":"BFEMMM201505986_CR37","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh K, Standley DM (2013) MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 30: 772\u2013780","journal-title":"Mol Biol Evol"},{"key":"BFEMMM201505986_CR38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4161\/mabs.1.5.9448","volume":"1","author":"B Kelley","year":"2009","unstructured":"Kelley B (2009) Industrialization of mAb production technology: the bioprocessing industry at a crossroads. MAbs 1: 443\u2013452","journal-title":"MAbs"},{"key":"BFEMMM201505986_CR39","unstructured":"Kitasato BU (1890) Ueber das Zustandekommender Diphterie\u2010Immunitat und der Tetanus\u2010Immunitat. Deutsche Medizinische Wochenschrift"},{"key":"BFEMMM201505986_CR40","first-page":"2453","volume":"174","author":"G Kohler","year":"2005","unstructured":"Kohler G, Milstein C (2005) Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. J Immunol 174: 2453\u20132455","journal-title":"J Immunol"},{"key":"BFEMMM201505986_CR41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9343(50)90224-5","volume":"8","author":"H Koprowski","year":"1950","unstructured":"Koprowski H, Van Der Scheer J, Black J (1950) Use of hyperimmune anti\u2010rabies serum concentrates in experimental rabies. Am J Med 8: 412\u2013420","journal-title":"Am J Med"},{"key":"BFEMMM201505986_CR42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","volume":"58","author":"J de Kruif","year":"2007","unstructured":"de Kruif J, Bakker AB, Marissen WE, Kramer RA, Throsby M, Rupprecht CE, Goudsmit J (2007) A human monoclonal antibody cocktail as a novel component of rabies postexposure prophylaxis. Annu Rev Med 58: 359\u2013368","journal-title":"Annu Rev Med"},{"key":"BFEMMM201505986_CR43","first-page":"37","volume":"5","author":"NA Kuzimina","year":"2013","unstructured":"Kuzimina NA, Kuzmin IV, Ellison JA, Rupprecht CE (2013) Conservation of binding epitopes for monoclonal antibodies on the rabies virus glycoprotein. Journal of Antiviral and Antiretrovirals 5: 37\u201343","journal-title":"Journal of Antiviral and Antiretrovirals"},{"key":"BFEMMM201505986_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virusres.2010.01.018","volume":"149","author":"IV Kuzmin","year":"2010","unstructured":"Kuzmin IV, Mayer AE, Niezgoda M, Markotter W, Agwanda B, Breiman RF, Rupprecht CE (2010) Shimoni bat virus, a new representative of the Lyssavirus genus. Virus Res 149: 197\u2013210","journal-title":"Virus Res"},{"key":"BFEMMM201505986_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3201\/eid1301.060810","volume":"13","author":"M Mallewa","year":"2007","unstructured":"Mallewa M, Fooks AR, Banda D, Chikungwa P, Mankhambo L, Molyneux E, Molyneux ME, Solomon T (2007) Rabies encephalitis in malaria\u2010endemic area, Malawi, Africa. Emerg Infect Dis 13: 136\u2013139","journal-title":"Emerg Infect Dis"},{"key":"BFEMMM201505986_CR46","first-page":"1","volume":"57","author":"SE Manning","year":"2008","unstructured":"Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR et\u00a0al (2008) Human rabies prevention\u2013United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 57: 1\u201328.","journal-title":"MMWR Recomm Rep"},{"key":"BFEMMM201505986_CR47","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","volume":"79","author":"WE Marissen","year":"2005","unstructured":"Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters\u2010van der Horst M, Visser TJ et\u00a0al (2005) Novel rabies virus\u2010neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol 79: 4672\u20134678","journal-title":"J Virol"},{"key":"BFEMMM201505986_CR48","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3201\/eid1804.111553","volume":"18","author":"DA Marston","year":"2012","unstructured":"Marston DA, Horton DL, Ngeleja C, Hampson K, McElhinney LM, Banyard AC, Haydon D, Cleaveland S, Rupprecht CE, Bigambo M et\u00a0al (2012) Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet. Emerg Infect Dis 18: 664\u2013667","journal-title":"Emerg Infect Dis"},{"key":"BFEMMM201505986_CR49","volume-title":"Laboratory Techniques in Rabies","author":"FX Meslin","year":"1996","unstructured":"Meslin FX, Kaplan MM, Koprowski H (eds) 1996 Laboratory Techniques in Rabies, 4th edn. Geneva, Switzerland: World Health Organization","edition":"4th"},{"key":"BFEMMM201505986_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ANTI.S33533","volume":"4","author":"T Nagarajan","year":"2014","unstructured":"Nagarajan T, Marissen WE, Rupprecht CE (2014) Monoclonal antibodies for the prevention of rabies: theory and clinical practice. Antibody Technol J 4: 1\u201312","journal-title":"Antibody Technol J"},{"key":"BFEMMM201505986_CR51","unstructured":"OIE World Organization for Animal Health (2013) Rabies. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals"},{"key":"BFEMMM201505986_CR52","doi-asserted-by":"crossref","first-page":"D5","DOI":"10.1093\/nar\/gkn741","volume":"37","author":"EW Sayers","year":"2009","unstructured":"Sayers EW, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V, Church DM, DiCuccio M, Edgar R, Federhen S et\u00a0al (2009) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 37: D5\u2013D15","journal-title":"Nucleic Acids Res"},{"key":"BFEMMM201505986_CR53","doi-asserted-by":"crossref","first-page":"3.13.1","DOI":"10.1002\/0471250953.bi0313s48","volume":"48","author":"F Sievers","year":"2014","unstructured":"Sievers F, Higgins DG (2014) Clustal omega. Curr Protoc Bioinformatics 48: 3.13.1\u20133.13.16","journal-title":"Curr Protoc Bioinformatics"},{"key":"BFEMMM201505986_CR54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2307\/4593681","volume":"84","author":"RK Sikes","year":"1969","unstructured":"Sikes RK (1969) Human rabies immune globulin. Public Health Rep 84: 797\u2013801","journal-title":"Public Health Rep"},{"key":"BFEMMM201505986_CR55","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","volume":"25","author":"SE Sloan","year":"2007","unstructured":"Sloan SE, Hanlon C, Weldon W, Niezgoda M, Blanton J, Self J, Rowley KJ, Mandell RB, Babcock GJ, Thomas WD Jr et\u00a0al (2007) Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates. Vaccine 25: 2800\u20132810","journal-title":"Vaccine"},{"key":"BFEMMM201505986_CR56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H (2008) Efficient generation of monoclonal antibodies from single human B cells by single cell RT\u2010PCR and expression vector cloning. J Immunol Methods 329: 112\u2013124","journal-title":"J Immunol Methods"},{"key":"BFEMMM201505986_CR57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","volume":"10","author":"E Traggiai","year":"2004","unstructured":"Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R, Lanzavecchia A (2004) An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 10: 871\u2013875","journal-title":"Nat Med"},{"key":"BFEMMM201505986_CR58","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1371\/journal.pntd.0000224","volume":"2","author":"MJ Warrell","year":"2008","unstructured":"Warrell MJ, Riddell A, Yu LM, Phipps J, Diggle L, Bourhy H, Deeks JJ, Fooks AR, Audry L, Brookes SM et\u00a0al (2008) A simplified 4\u2010site economical intradermal post\u2010exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl Trop Dis 2: e224","journal-title":"PLoS Negl Trop Dis"},{"key":"BFEMMM201505986_CR59","first-page":"747","volume":"45","author":"TJ Wiktor","year":"1971","unstructured":"Wiktor TJ, Lerner RA, Koprowski H (1971) Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination. Bull World Health Organ 45: 747\u2013753","journal-title":"Bull World Health Organ"},{"key":"BFEMMM201505986_CR60","unstructured":"World Health Organization (2013) WHO Experts Consultation on Rabies. Second report World Health Organ Tech Rep Ser (982): 1\u2013139"},{"key":"BFEMMM201505986_CR61","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","volume":"89","author":"E Wright","year":"2008","unstructured":"Wright E, Temperton NJ, Marston DA, McElhinney LM, Fooks AR, Weiss RA (2008) Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross\u2010species comparison. J Gen Virol 89: 2204\u20132213","journal-title":"J Gen Virol"},{"key":"BFEMMM201505986_CR62","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.1016\/j.vaccine.2009.09.024","volume":"27","author":"E Wright","year":"2009","unstructured":"Wright E, McNabb S, Goddard T, Horton DL, Lembo T, Nel LH, Weiss RA, Cleaveland S, Fooks AR (2009) A robust lentiviral pseudotype neutralisation assay for in\u2010field serosurveillance of rabies and lyssaviruses in Africa. Vaccine 27: 7178\u20137186","journal-title":"Vaccine"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201505986.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201505986","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201505986\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201505986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201505986.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:14:04Z","timestamp":1779084844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201505986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,18]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4,1]]}},"alternative-id":["BFEMMM201505986"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201505986","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726227015.793528366","asserted-by":"object"}]},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,18]]},"assertion":[{"value":"2 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PDB, RA, BZ, AS, GC, and IC are employed by IZSVe. RL, ALe, and HB are employed by IP\u2010Paris, and AM, GA, FV, and DC are employed by Humabs BioMed SA. ALa is the scientific founder of Humabs BioMed SA and holds shares in Humabs BioMed SA. This does not alter our adherence to all EMBO press journals policies on sharing data and materials.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}